Medicine and Dentistry
Inpatient
100%
Heart Failure
75%
Heart Ventricle Remodeling
50%
Placebo
32%
Dapagliflozin
32%
Diabetes
28%
Patient
26%
Lymphocyte
25%
Glucose
25%
Randomized Controlled Trial
25%
Heart Failure with Reduced Ejection Fraction
25%
Sodium
25%
Left Ventricular Hypertrophy
25%
Glycon
25%
Coronary Artery Disease
25%
Patient with Diabetes
25%
Heart Failure with Preserved Ejection Fraction
25%
Neutrophil
25%
Cotransporter
25%
Diabetes Mellitus
25%
Cardiovascular System
14%
Maturity Onset Diabetes of the Young
12%
Cardiac Magnetic Resonance Imaging
11%
Therapeutic Procedure
11%
Insulin Resistance
10%
End-Systolic Volume
8%
Serositis
8%
Patient with Type 2 Diabetes
8%
Combination Therapy
7%
Biological Marker
7%
Impaired Glucose Tolerance
7%
Antidiabetic Agent
7%
Body Weight
7%
Oxidative Stress
7%
Controlled Clinical Trial
7%
Pharmacology, Toxicology and Pharmaceutical Science
Heart Failure
25%
Sodium
25%
Cotransporter
25%
Heart Ventricle Remodeling
25%
Diabetes Mellitus
25%
Glucose
25%
Dapagliflozin
7%
Placebo
7%
Clinical Trial
7%
Antidiabetic Agent
7%